Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2

European Journal of Haematology

Volumn 57, Issue 2, 1996, Pages 149-156

  Guedez, Liliane ^b   Suresh, Alaparthy ^b   Tung, Frank ^b   Zucali, James ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

1 arabinofuranosylcytosine (Ara C); Apoptosis; bcl 2; Myeloid leukemias; U 937 cells

Indexed keywords

CYTARABINE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSIS; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0029787087     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb01353.x     Document Type: Article

References (33)

1. TSUJIMOTO Y, CROCE C. Analysis of the structure, transcripts and protein product for bcl-2, the gene involved in human follicular lymphomas. Proc Natl Acad Sci (USA). 1986: 83: 5214-5218.
2. CLEARY M, SMITH S, SKLAR J. Cloning and structural analysis of cDNAs for bcl-2/immunoglobulin transcripts resulting from the t(14;18) translocation. Cell 1986: 47: 9-28.
3. HOCKENBERY D, OLTVAI Z, YIN X, MILLIMAN C, KORSMEYER S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993: 75: 241-257.
4. KANE D, SARAFIAN T, ANTON R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993: 262: 1274-1277.
5. TANAKA S, SAITO K, REED J. Structure and function analysis of bcl-2 oncoprotein. J Biol Chem 1993: 268: 10920-10926.
6. ++ fluxes. Proc Natl Acad Sci (USA) 1994: 91: 6569-6573.
7. MIYASHITA T, REED J. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993: 81: 151-157.
8. WALTON M, WHYSONG D, O'CONNOR P, HOCKENBERY D, KORSMEYER S, KOHN K. Constitutive expression of bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993: 53: 1853-1861.
9. NUNEZ G, SETO M, SEREMETIS S, et al. Growth and antitumor promoting effects of deregulated bcl-2 in human B-lymphoblastoid cells. Proc Natl Acad Sci (USA) 1989: 86: 4589-4593.
10. FISHER T, MILNER A, GREGORY C, et al. Bcl-2 modulation of apoptosis induced by anti-cancer drugs: Resistance to thymidylate stress is independent from the classical resistance pathways. Cancer Res 1993: 53: 3321-3326.
11. DELIA D, AIELLO A, SOLIGO D, et al. Bcl-2 oncogene expression in normal and neoplastic human myeloid cells. Blood 1992: 79: 1291-1298.
12. LOTEM J, SACHS L. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Diff 1994: 5: 321-327.
13. SUGIMOTO K, TOYOSHIMA H, SAKAI R, et al. Frequent mutations in p53 gene in human myeloid leukemia cell lines. Blood 1992: 79: 2379-2383.
14. CAMPOS L, ROUAULT J, SABIDO O, et al. High expression of bcl-2 protein in acute myelogenous leukemia cells is associated with poor response to chemotherapy. Blood 1993: 81: 3091-3096.
15. RUSSELL N, HUNATE A, BRADBURY D, ZHU Y, KEITH F. Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloid leukaemia. Leuk Lymph 1995: 16: 323-329.
16. CHABNER B, MYERS C. Clinical pharmacology of cancer chemotherapy. In: DEVITA V, HELLMAN S, ROSENBERG S, eds. Principles and Practice of Oncology. Philadelphia: JB Lippincott Co: 1993: 349.
17. BHALLA K, NAYAK R, GRANT S. Isolation and characterization of deoxyxytidine kinase deficient, human promyelocytic leukemia cell line highly resistant to 1-β-d-arabinofuranosylcytosine. Cancer Res 1984: 44: 50-59.
18. GUNJI H, KHARBANDA S, KUFE, D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-d-arabinofuranosylcytosine. Cancer Res 1991: 51: 741-743.
19. HEINEMANN V, JHEN U. Rationale for the pharmacologically optimized treatment of acute non lymphocytic leukemia with cytosine arabinoside. Leukemia 1990: 4: 790-796.
20. HERZIG R, WOLFF S, LAZARUS H, PHILLIPS G, HERZIG G. High dose cytosine arabinoside therapy for refractory leukemia. Blood 1983: 62: 361-369.
21. KEITH F, BRADBURY D, ZHU Y, RUSSELL N. Inhibition of bcl-2 with oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia 1995: 9: 131-138.
22. BRADBURY D, ZHU Y-M, RUSSELL N. Regulation of bcl-2 expression and apoptosis in acute myeloblastic leukemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 1994: 8: 786-791.
23. DARZYNKIEWCZ Z. Detection of DNA strand breaks associated with apoptosis. In: ROBINSON P, ed. Handbook of Flow Cytometry Methods. Philadelphia: JB Lippincott Co: 1993: 349.
24. DENG G, PODACK E. Suppresion of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of protooncogene bcl-2. Proc Natl Acad Sci (USA) 1993: 90: 2189-2193.
25. KARASUYAMA H, MELCHERS D. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988: 18: 97-104.
26. SURESCH A, TUNG F, MOREB J, ZUCALI Z. Role of manganese superoxide dismutase in radioprotection using gene transfer studies. Cancer Gene Ther 1994: 1: 85-89.
27. SAMBROOK J, FRISTCH E, MANIATIS T. Molecular Cloning: A Laboratory Manual. NOLAN C, ed. New York: Cold Spring Harbor Laboratory Press: 1989.
28. CHIRGWING J, PRZYBYLA H, MCDONALD R, RUTTER W. Isolation of biologically active ribonucleic acid. Biochemistry 1979: 18: 5294-5298.
29. NUNEZ G, LONDON L, D, ALEXANDER M, MCKEARN J, KORSMEYER S. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor deprived hematological cell lines. J Immunol 1990: 144: 3602-3610.
30. HICKMAN J. Apoptosis induced by anti-cancer drugs. Cancer Metast Rev 1992: 11: 121-139.
31. MAJOR P, EGAN E, BEARDSLEY G, MINDEN M, KUFE D. Lethality of human myeloblasts correlates with the incorporation of Ara-C into DNA. Proc Natl Acad Sci (USA) 1981: 78: 3235-3239.
32. CAMPOS L, SABIDO O, ROUAULT J, GUYOTAT D. Effects of bcl-2 oligodeoxynucleotides on in vitro proliferation and survival on normal marrow progenitors and leukemic cells. Blood 1994: 84: 595-600.
33. MANOME Y, WEICHSELBAUM R, KUFE D, FINE H. Effect of bcl-2 on ionizing radiation and 1-β-d-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Oncol Res 1993: 5: 139-144.